| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5705474 | Ophthalmology | 2017 | 8 Pages |
Abstract
Lifitegrast significantly improved symptoms of eye dryness, as measured by EDS, versus placebo in participants with DED. Improvement in EDS was observed as early as day 14. Lifitegrast appeared well tolerated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Edward J. MD, Jodi MD, Paul M. OD, FAAO, Kelly K. OD, PhD, Mitchell A. MD, Kenneth MD, Joseph MD, Monica OD, MPH, Aparna PhD, Amir PharmD, PhD,